DuChemBIO Co.,Ltd. (KOSDAQ:176750)

Market Cap	307.54B
Revenue (ttm)	35.60B
Net Income (ttm)	7.99B
Shares Out	28.34M
EPS (ttm)	297.54
PE Ratio	36.47
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	820,647
Average Volume	1,199,908
Open	8,260.00
Previous Close	8,300.00
Day's Range	7,760.00 - 8,410.00
52-Week Range	5,360.00 - 19,570.00
Beta	0.00
RSI	27.83
Earnings Date	n/a

About DuChemBIO

DuChemBIO Co.,Ltd. engages in the development, production, and sale of radiopharmaceutical products for cancer diagnosis and treatment in South Korea. Its products include FP-CIT for diagnosis of Parkinson’s disease and Parkinson's syndrome by measuring the density of dopamine transporters present in the brain striatum; F-DOPA for brain tumor diagnosis with neutralization technology; Neuraceq for diagnosis of Alzheimer's disease by measuring the distribution and density of beta amyloid in the brain; and Vizamyl for early diagnosis of beta amylo...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 2002
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 176750